Your browser doesn't support javascript.
loading
Pathologic features and clinical course of a non-functioning primary pulmonary paraganglioma: A case report.
Tobón, Angélica; Velásquez, Mauricio; Pérez, Bladimir; Zúñiga, Valeria; Sua, Luz F; Fernández-Trujillo, Liliana.
Afiliação
  • Tobón A; Faculty of Health Sciences, Department of Internal Medicine, Universidad Icesi, Cali, Colombia.
  • Velásquez M; Department of Surgery, Thoracic Surgery Service, Fundación Valle del Lili, Cali, Colombia.
  • Pérez B; Faculty of Health Sciences, Department of Internal Medicine, Universidad Icesi, Cali, Colombia.
  • Zúñiga V; Department of Pathology and Laboratory Medicine, Fundación Valle del Lili, Cali, Colombia.
  • Sua LF; Faculty of Health Sciences, Department of Internal Medicine, Universidad Icesi, Cali, Colombia.
  • Fernández-Trujillo L; Clinical Research Center, Fundación Valle del Lili, Cali, Colombia.
Ann Med Surg (Lond) ; 55: 185-189, 2020 Jul.
Article em En | MEDLINE | ID: mdl-32514340
INTRODUCTION: Paragangliomas (PGGL) are rare neuroendocrine tumors arising from non-epithelial extra-adrenal chromaffin cells. They have been described in different sites: abdomen, pelvis, head, neck and thorax. Incidence is very low, occurring in less than 2-8/million per year. PGGL's of the lung are extremely rare, they have a slow growth and present as painless lesions. Biopsy is the method of choice for diagnosis and prognosis. PRESENTATION OF CASE: This is a 70-year-old woman with chronic cough, with a CT-scan showing a 3.3-cm mass in the left lower lobe. After video-assisted thoracic surgery, histologic findings confirmed a non-functioning pulmonary paraganglioma. We present the clinical, radiological, pathological findings and clinical course. DISCUSSION: Primary pulmonary PGGL's are extremely rare neuroendocrine tumors with low-grade malignancy, difficult to distinguish from other pulmonary tumors relying only on imaging techniques. In this case, PGGL presented as an incidentaloma during the evaluation of chronic cough. After histological diagnosis, genetic testing are ideally performed to identify somatic or germline mutations that may condition a higher risk of malignancy and metastasis. CONCLUSION: PGGL's must be considered when other diagnoses are unlikely due to immunohistochemistry findings. Larger studies in this field are needed to determine the risk factors for its development and to determine which populations have the greatest potential for malignant transformation.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ann Med Surg (Lond) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Colômbia País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ann Med Surg (Lond) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Colômbia País de publicação: Reino Unido